RecruitingNCT06537037

Exploring the Association of Imaging and Tumor Microenvironment in Urologic Cancer Using Radiogenomic Approach（Radiogenomics-Urinary）

Sponsor

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Enrollment

150 participants

Start Date

Aug 1, 2024

Study Type

OBSERVATIONAL

Conditions

Urologic Cancer

Summary

This is the prospective, observational cohort study (Radiogenomics-Urinary), which aims to explore the relationship between the imaging information of urologic cancer patients, tumor microenvironment and the prognosis of urologic cancer patients.

Eligibility

Min Age: 18 Years

Inclusion Criteria4

Patients treated for urologic cancer in Wuhan Union Hospital from August 2024 to August 2027;
Aged > 18 years old;
At least one CT scan or MRI scan before treatment;
Tissue biopsy pathological examination confirmed the diagnosis of the above tumors.

Exclusion Criteria4

Poor image quality;
Incomplete clinical data or loss of follow-up;
Presence of another primary malignancy other than urologic cancer;
Unclear pathological diagnosis。

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Union Hospital，Tongji Medical College，Huazhong University of Science and Technology

Wuhan, Hubei, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06537037

Related Trials

Web-Based Application for Monitoring Radiation Therapy Complications in Cancer Patients

NCT074166301 location

VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic Therapy

NCT059203431 location